In the BioHarmony Drug Report Database

"Preview" Icon

Ketamine

Ketalar, Spravato (ketamine) is a small molecule pharmaceutical. Ketamine was first approved as Ketalar on 1982-01-01. It is used to treat burns and pain in the USA. It has been approved in Europe to treat depressive disorder. The pharmaceutical is active against glutamate receptor ionotropic, NMDA 2C, glutamate receptor ionotropic, NMDA 2A, glutamate receptor ionotropic, NMDA 2D, and glutamate receptor ionotropic, NMDA 2B.

 

Trade Name

 

Spravato
 

Common Name

 

ketamine
 

ChEMBL ID

 

CHEMBL742
 

Indication

 

burns, depressive disorder, pain
 

Drug Class

 

Nmda receptor antagonists; General anesthetics; Dissociative hallucinogens; Analgesics; Antidepressants

Image (chem structure or protein)

Ketamine structure rendering